PETER G. TRABER - 24 May 2021 Form 4 Insider Report for SELECTA BIOSCIENCES INC (RNAC)

Role
Chief Medical Officer
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Peter G. Traber
Issuer symbol
RNAC
Transactions as of
24 May 2021
Net transactions value
+$58,898
Form type
4
Filing time
26 May 2021, 16:33:32 UTC
Next filing
27 May 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SELB Common Stock Purchase $41,498 +12,500 +13% $3.32 110,500 24 May 2021 Direct F1
transaction SELB Common Stock Purchase $17,400 +5,000 +4.5% $3.48 115,500 25 May 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $3.315 to $3.32. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.